NCT05897957View on ClinicalTrials.gov

Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01

Enrolling by invitationOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

May 31, 2027

Study Completion Date

September 30, 2027

Conditions
Parkinson Disease
Trial Locations (3)

10065

Weill Cornell Medical College, New York

92868

University of California, Irvine, Orange

M5T 2S8

Toronto Western Hospital, Toronto

Sponsors
All Listed Sponsors
lead

BlueRock Therapeutics

INDUSTRY

NCT05897957 - Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01 | Biotech Hunter | Biotech Hunter